View EO 12866 Meeting 1117-AB40

  Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have not had a Prior In-Person Medical Evaluation

  1117-DOJ/DEA

  Proposed Rule Stage

  07/10/2024 02:30 PM

  on behalf of the National Council for Mental Wellbeing   Chris Adamec


 
List of Documents
Group Letter to DEA Re Schedule IIN Mental Health - June 11 2024
Final Letter to DEA Re Schedule IIN Mental Health - June 11 2024
 
List of Attendees Participation
•   Bethany DiPaula Pharm.D., BCPP, FASHP  - American Association of Psychiatric Pharmacists / University of Maryland School of Pharmacy Teleconference 
•   Rochelle Archuleta  - National Association for Behavioral Healthcare Teleconference 
•   Stephanie Katz  - National Council for Mental Wellbeing Teleconference 
•   Brenda Schimenti, MS  - American Association of Psychiatric Pharmacists Teleconference 
•   Karen Ferguson  - American Academy of Child and Adolescent Psychiatry Teleconference 
•   Jad Hilal, M.D.  - American Academy of Child and Adolescent Psychiatry Teleconference 
•   Brooke Trainum  - American Psychiatric Association Teleconference 
•   Shabana Khan, M.D.   - American Psychiatric Association Teleconference 
•   Ingrid Alpern, JD  - Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Teleconference 
•   Kathryn Cohen  - Association for Behavioral Health and Wellness Teleconference 
•   Judy Brewer  - OSTP Teleconference 
•   Jenna Bluestein  - ONDCP Teleconference 
•   Jax Nally  - DPC Teleconference 
•   Kathleen Comando  - DPC In Person 
•   Jane Eyre  - ONDCP Teleconference 
•   Rachel Patterson  - DPC Teleconference 
•   John Lindner  - OMB Teleconference 
•   Sreeja Condeti  - OMB Teleconference 
•   Chris Adamec  - Sirona Strategies Teleconference 
•   Andrew Braxton. Strickland  - American Psychological Association Teleconference 
•   Joe Nye  - OMB/OIRA Teleconference 
•   Terri Tanielian  - WHO Teleconference